Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Operating Expenses: 2018-2020

Historic Other Operating Expenses for Outlook Therapeutics (OTLK) over the last 1 years, with Jun 2020 value amounting to $104,296.

  • Outlook Therapeutics' Other Operating Expenses rose 104.80% to $104,296 in Q2 2020 from the same period last year, while for Jun 2020 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $527,624 for FY2020, which is 95.32% down from last year.
  • According to the latest figures from Q2 2020, Outlook Therapeutics' Other Operating Expenses is $104,296, which was down 75.36% from $423,328 recorded in Q1 2020.
  • Outlook Therapeutics' Other Operating Expenses' 5-year high stood at $8.3 million during Q3 2019, with a 5-year trough of $50,927 in Q2 2019.
  • Over the past 3 years, Outlook Therapeutics' median Other Operating Expenses value was $492,532 (recorded in 2019), while the average stood at $2.0 million.
  • The largest annual percentage gain for Outlook Therapeutics' Other Operating Expenses in the last 5 years was 104.80% (2020), contrasted with its biggest fall of 24.64% (2020).
  • Quarterly analysis of 3 years shows Outlook Therapeutics' Other Operating Expenses stood at $2.3 million in 2018, then reached $8.3 million in 2019, then skyrocketed by 104.80% to $104,296 in 2020.
  • Its Other Operating Expenses stands at $104,296 for Q2 2020, versus $423,328 for Q1 2020 and $8.3 million for Q3 2019.